Umano Healthcare Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
as on 23-12-2024
- Paid Up Capital ₹ 9.99 Cr
as on 23-12-2024
- Company Age 13 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Revenue 44.81%
(FY 2023)
- Profit -12.17%
(FY 2023)
- Ebitda -17.42%
(FY 2023)
- Net Worth -12.25%
(FY 2023)
- Total Assets 22.40%
(FY 2023)
About Umano Healthcare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 9.99 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ashwani Kumar, Sanjeev Kumar, and Rajiv Kumar serve as directors at the Company.
- CIN/LLPIN
U24297DL2011PTC227673
- Company No.
227673
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Nov 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Umano Healthcare?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashwani Kumar  | Director | 19-Jun-2012 | Current |
| Sanjeev Kumar | Director | 09-Dec-2013 | Current |
| Rajiv Kumar | Director | 21-Nov-2011 | Current |
Financial Performance of Umano Healthcare.
Umano Healthcare Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 44.81% increase. The company also saw a substantial fall in profitability, with a 12.17% decrease in profit. The company's net worth observed a substantial decline by a decrease of 12.25%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Umano Healthcare?
In 2023, Umano Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
United Biotech Private LimitedActive 27 years 10 monthsAshwani Kumar, Sanjeev Kumar and 1 more are mutual person
Sarash Biocare Private LimitedActive 6 years 3 monthsAshwani Kumar, Sanjeev Kumar and 1 more are mutual person
- Feliz Lifecare Private LimitedActive 13 years 1 month
Ashwani Kumar, Sanjeev Kumar and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Umano Healthcare?
Umano Healthcare has a workforce of 189 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Umano Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Umano Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
